These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 747216)

  • 1. [The eosinophil and atopic dermatitis].
    Orea Solano M; Cueva Velázquez J
    Alergia; 1978 Oct; 25(4):175-80. PubMed ID: 747216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rosette-forming properties of the eosinophils and their use for the diagnosis and prognosis of atopic dermatitis in children].
    Mazina NM; Avdeeva ZhI; Mannanov AM
    Vestn Dermatol Venerol; 1988; (5):19-22. PubMed ID: 3176657
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
    Nishimoto M; Numahara T; Nakashima K; Yoshida T
    Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eosinophils and atopic dermatitis].
    Orea Solano M; Cueva Velázquez J
    Alergia; 1979 Apr; 26(2):59-64. PubMed ID: 464246
    [No Abstract]   [Full Text] [Related]  

  • 6. No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.
    Oldhoff JM; Darsow U; Werfel T; Bihari IC; Katzer K; Laifaoui J; Plötz S; Kapp A; Knol EF; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
    Int Arch Allergy Immunol; 2006; 141(3):290-4. PubMed ID: 16931891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils are neither migrated nor activated in the skin lesions of atopic dermatitis in infants.
    Kondo N; Shinoda S; Fukutomi O; Agata H; Terada T; Shikano H; Montaño AM; Sakaguchi H; Watanabe M; Komiyama K; Yokoyama Y; Morimoto N
    J Investig Allergol Clin Immunol; 2000; 10(1):11-3. PubMed ID: 10780793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophils: current knowledge and clinical usefulness in childhood].
    Calbi M; Scala G; Guida L; Merolla E; Bianco G; Giacchetti L
    Pediatr Med Chir; 1993; 15(6):555-62. PubMed ID: 8197013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low breast milk IgA and high blood eosinophil count in breast-fed newborns determine higher risk for developing atopic eczema after an 18-month follow-up.
    Calbi M; Giacchetti L
    J Investig Allergol Clin Immunol; 1998; 8(3):161-4. PubMed ID: 9684189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro immunological studies in atopic and contact dermatitis.
    Bousquet J; Andary M; Clot J; Guilhou DJ; Meynadier J
    Ann Allergy; 1978 Sep; 41(3):170-5. PubMed ID: 686511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Borgerding E; Feldman SR
    Cutis; 2010 Oct; 86(4):208-13. PubMed ID: 21140931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-induced apoptosis of eosinophils in atopic dermatitis patients.
    Matsukura M; Yamada H; Yudate T; Tezuka T; Chihara J
    J Clin Lab Immunol; 1996; 48(3):109-22. PubMed ID: 10036642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific IgE in atopic dermatitis.
    Ohman S; Johansson SG
    Acta Derm Venereol; 1974; 54(4):283-90. PubMed ID: 4136514
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum levels of anti-Staphylococcus aureus-specific IgE in patients with atopic dermatitis.
    Yamada H; Yudate T; Orita T; Tezuka T
    J Clin Lab Immunol; 1996; 48(4):167-75. PubMed ID: 9819668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.
    Kagaya S; Hashida R; Ohkura N; Tsukada T; Sugita Y; Terakawa M; Tsujimoto G; Katsunuma T; Akasawa A; Matsumoto K; Saito H
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():35-44. PubMed ID: 15947483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast treatment in children with moderately severe atopic dermatitis.
    Ehlayel MS; Bener A; Sabbah A
    Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):232-6. PubMed ID: 18236999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atopic dermatitis and eosinophils].
    Yoshida H; Maeda K; Tanaka Y; Anan S
    Arerugi; 1991 May; 40(5):489-93. PubMed ID: 1883263
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating ICAM-1 levels in children with atopic dermatitis.
    Kojima T; Ono A; Aoki T; Kameda-Hayashi N; Kobayashi Y
    Ann Allergy; 1994 Oct; 73(4):351-5. PubMed ID: 7944004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of serum eosinophil cationic protein levels by cyclosporin in severe atopic dermatitis.
    Caproni M; D'Agata A; Cappelli G; Fabbri P
    Br J Dermatol; 1996 Aug; 135(2):336-7. PubMed ID: 8881695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.